Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab
Seth M. Pollack, MD, Fred Hutchinson Cancer Research Center, explains Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab at ASCO 2018
Author: Annual-Meeting
Added: 06/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts